To apply the treatment strategy via tumor microenvironment modulation, we developed a BBB-penetrating delivery strategy in this present work by using a new design of dual-targeting liposome modified with T12 peptide and anti-PD-L1 nanobody. This evidence concerns the gene CD274 and neoplasm.